Dr. Chandy earned his MD and Ph.D. in 2008, at Pennsylvania State University. After completing medical school, Dr. Chandy trained in Internal Medicine at the University of British Columbia, followed by a Cardiology fellowship at the University of Toronto. He also completed a fellowship in Echocardiography and enrolled in the Clinician Scientist Training Program at the University of Toronto. With a desire to learn stem cell biology, Dr. Chandy trained in the laboratory of Dr. Joseph Wu, a world-renowned expert in induced pluripotent stem cells (iPSCs) and the Director of the Stanford Cardiovascular Institute. Dr. Chandy’s research has been published in Cell and other high-impact journals. He holds
patents for his novel discoveries. As a recently appointed Assistant Professor at the University of Western Ontario, Dr. Chandy is an
independent physician-scientist using iPSC disease modeling, next-generation sequencing (NGS), proteomics, and gene editing to understand the mechanisms of cardiovascular disease. Dr. Chandy's current research focuses on understanding the pathophysiology of environmental exposures such as air pollution, e-cigarettes, and marijuana on cardiovascular disease using human iPSC-derived tissue. The overarching goal of his research is to 1) investigate the effects of the environment on the cardiovascular system, 2) discover biomarkers to risk stratify patients, and 3) discover druggable target genes for cardiovascular disease.